Boston Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$1.37M Buy
73,869
+24,293
+49% +$450K 0.07% 337
2019
Q2
$922K Sell
49,576
-84,983
-63% -$1.58M 0.05% 379
2019
Q1
$3.29M Buy
134,559
+109,819
+444% +$2.68M 0.17% 167
2018
Q4
$642K Buy
24,740
+2,595
+12% +$67.3K 0.04% 411
2018
Q3
$701K Buy
22,145
+3,040
+16% +$96.2K 0.03% 434
2018
Q2
$742K Sell
19,105
-8,550
-31% -$332K 0.02% 433
2018
Q1
$763K Buy
+27,655
New +$763K 0.02% 422